US 10894052
Heterocyclic inhibitors of ATR kinase
granted A61KA61K31/5377A61P
Quick answer
US patent 10894052 (Heterocyclic inhibitors of ATR kinase) held by The Board of Regents of the University of Texas System expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jan 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K31/5377, A61P, A61P35/00